MAZE THERAPEUTICS, INC. (MAZE)

SEC filing

MAZE THERAPEUTICS, INC.

MAZE · CIK 1842295

4 · Dec 31, 2025 · Dandekar Atul sold 72.50K shares at $40.56/share ($2.9M); exercised options for 72.50K shares

Dandekar Atul sold 72.50K shares at $40.56/share ($2.9M); exercised options for 72.50K shares

xslF345X05/form4-12312025_091220.xml

xslF345X05/form4-12312025_091220.xmlSEC.gov

Graphics and non-inline formats (not embedded below).